Skip to content
10-Q

Quarterly Report

Statera Biopharma, Inc.

0001437749-22-027371

← back to feed
Filed
Nov 14, 2022 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2022 · Nov 3, 2022 54.66M sh
Capex Q3 2022 · Sep 30, 2022 $6.45K
Capex Q3 2022 · Sep 30, 2021 $86.06K
Operating Cash Flow Q3 2022 · Sep 30, 2022 −$4.73M
Operating Cash Flow restated Q3 2022 · Sep 30, 2021 −$20.83M
Long Term Debt Q3 2022 · Sep 30, 2022 $0
Long Term Debt Q3 2022 · Dec 31, 2021 $10.63M
Short Term Investments Q3 2022 · Sep 30, 2022 $0
Short Term Investments Q3 2022 · Dec 31, 2021 $134.6K
Cash And Equivalents Q3 2022 · Sep 30, 2022 $506.1K
Cash And Equivalents Q3 2022 · Dec 31, 2021 $1.84M
Stockholders Equity Q3 2022 · Sep 30, 2022 −$10.24M
Stockholders Equity Q3 2022 · Dec 31, 2021 −$1.57M
Current Liabilities Q3 2022 · Sep 30, 2022 $22.23M
Current Liabilities Q3 2022 · Dec 31, 2021 $11.25M
Total Liabilities Q3 2022 · Sep 30, 2022 $22.92M
Total Liabilities Q3 2022 · Dec 31, 2021 $22.68M
Current Assets Q3 2022 · Sep 30, 2022 $1.21M
Current Assets Q3 2022 · Dec 31, 2021 $4.15M
Total Assets Q3 2022 · Sep 30, 2022 $12.75M
Total Assets Q3 2022 · Dec 31, 2021 $21.17M
Eps Basic Q3 2022 · Sep 30, 2022 −$0.07
Eps Basic Q3 2022 · Sep 30, 2022 −$0.32
Eps Basic Q3 2022 · Sep 30, 2021 −$0.47
Eps Basic Q3 2022 · Sep 30, 2021 −$0.86
Rd Expense Q3 2022 · Sep 30, 2022 $230.6K
Rd Expense Q3 2022 · Sep 30, 2022 $4.45M
Rd Expense Q3 2022 · Sep 30, 2021 $3.43M
Rd Expense Q3 2022 · Sep 30, 2021 $6.27M
Net Income Q3 2022 · Sep 30, 2022 −$3.35M
Net Income Q3 2022 · Sep 30, 2022 −$14.59M
Net Income Q3 2022 · Sep 30, 2021 −$12.72M
Net Income Q3 2022 · Sep 30, 2021 −$24.61M
Operating Income Q3 2022 · Sep 30, 2022 −$1.55M
Operating Income Q3 2022 · Sep 30, 2022 −$11.01M
Operating Income Q3 2022 · Sep 30, 2021 −$9.64M
Operating Income Q3 2022 · Sep 30, 2021 −$21.16M
Gross Profit Q3 2022 · Sep 30, 2022 $501.12K
Gross Profit Q3 2022 · Sep 30, 2022 $1.71M
Gross Profit Q3 2022 · Sep 30, 2021 $120.59K
Gross Profit Q3 2022 · Sep 30, 2021 $120.59K
Cost Of Revenue Q3 2022 · Sep 30, 2022 $169.35K
Cost Of Revenue Q3 2022 · Sep 30, 2022 $723.96K
Cost Of Revenue Q3 2022 · Sep 30, 2021 $115.93K
Cost Of Revenue Q3 2022 · Sep 30, 2021 $115.93K
Revenue Q3 2022 · Sep 30, 2022 $670.47K
Revenue Q3 2022 · Sep 30, 2022 $2.44M
Revenue Q3 2022 · Sep 30, 2021 $236.52K
Revenue Q3 2022 · Sep 30, 2021 $236.52K